Dysmotility and ppi use are independent risk factors for small intestinal bacterial and/or fungal overgrowth

摘要

IntroductionWhether intestinal dysmotility and proton pump inhibitor (PPI) use either independently or together contributes to small intestinal bacterial overgrowth (SIBO), and/or small intestinal fungal overgrowth (SIFO) is not known.